Interorganizational Accounting: The Role of BRSR in Driving Accountability of Pharmaceutical Supply Chain

Pharmaceutical supply chains are significant players contributing to the economy of a nation. This has resulted in widespread pollution of the environment, harming both human health and the ecosystem. This study examines the business responsibility and sustainability reporting (BRSR) disclosures of 59 Indian pharmaceutical businesses (ranked in the top 1000 by 2025). The research employs a systematic process that includes data extraction using automation tools and analysis with Python libraries. The examination looks at a variety of topics, including product focus, operational efficiency, environmental performance, employees' demographics, and stakeholder involvement. The findings demonstrate differences in environmental, social, and governance (ESG) performance among organizations. As the study is on pharmaceutical companies, it also examines the attributes embedded in Good Manufacturing Practices (a system of rules and guidelines). To explain the phenomenon, the authors integrated insights from the resource‐based view and institutional theory. This research study has integrated interpretive structural modelling with structural equation modelling to identify the good manufacturing practices (GMP) drivers and enablers. The study was conducted at two levels. In the first level, experts were interviewed to understand the interrelationship between drivers and BRSR practices. In the second level, an interpretive structural model was developed, and the identified relationships were tested using structural equation modelling. The results revealed that regulatory pressure and competition were the key drivers for good manufacturing practices. This research provides significant insights for investors, policymakers, and the pharmaceutical sector as a whole in navigating the complicated terrain of sustainability reporting and making meaningful progress towards ESG goals.

Authors

Institutions

Publication Details

Journal
Business Strategy and the Environment
Published
2026-11-18
DOI
https://doi.org/10.1002/bse.71864
Primary Topic
Corporate Social Responsibility Reporting
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Interorganizational Accounting: The Role of BRSR in Driving Accountability of Pharmaceutical Supply Chain

Kali Charan Sabat, Ashu Sharma, Bala Krishnamoorthy, Anju Singh
2 links
Business Strategy and the Environment
Corporate Social Responsibility Reporting
article

Interorganizational Accounting: The Role of BRSR in Driving Accountability of Pharmaceutical Supply Chain

Kali Charan Sabat, Ashu Sharma, Bala Krishnamoorthy, Anju Singh
article en

Abstract

Pharmaceutical supply chains are significant players contributing to the economy of a nation. This has resulted in widespread pollution of the environment, harming both human health and the ecosystem. This study examines the business responsibility and sustainability reporting (BRSR) disclosures of 59 Indian pharmaceutical businesses (ranked in the top 1000 by 2025). The research employs a systematic process that includes data extraction using automation tools and analysis with Python libraries. The examination looks at a variety of topics, including product focus, operational efficiency, environmental performance, employees' demographics, and stakeholder involvement. The findings demonstrate differences in environmental, social, and governance (ESG) performance among organizations. As the study is on pharmaceutical companies, it also examines the attributes embedded in Good Manufacturing Practices (a system of rules and guidelines). To explain the phenomenon, the authors integrated insights from the resource‐based view and institutional theory. This research study has integrated interpretive structural modelling with structural equation modelling to identify the good manufacturing practices (GMP) drivers and enablers. The study was conducted at two levels. In the first level, experts were interviewed to understand the interrelationship between drivers and BRSR practices. In the second level, an interpretive structural model was developed, and the identified relationships were tested using structural equation modelling. The results revealed that regulatory pressure and competition were the key drivers for good manufacturing practices. This research provides significant insights for investors, policymakers, and the pharmaceutical sector as a whole in navigating the complicated terrain of sustainability reporting and making meaningful progress towards ESG goals.

Business Strategy and the Environment
Narsee Monjee Institute of Management Studies (IN), Dayananda Sagar College of Engineering (IN), Indian Institute of Management Mumbai (IN), Dr. Hari Singh Gour University (IN)
Responsible consumption and production, Industry, innovation and infrastructure
Corporate Social Responsibility Reporting
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon